Activation of fibroblast growth factor receptor 3 (FGFR3) has been reported to play important roles in several malignancies, including uterine cervix carcinoma and multiple myeloma as well as bladder cancers (BC)[1][2]. This evidence concerns the gene FGFR3 and urinary bladder cancer.